DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Schneeweiss A, Lux MP, Hartkopf AD. et al.
Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167). San Antonio Breast Cancer Symposium 2018; Abstr. P6-17-22.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.